Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
60
SPNT Quote, Financials, Valuation and Earnings
Last price:
$19.10
Seasonality move
:
-0.51%
Day range:
$18.29 - $18.74
52-week range:
$12.78 - $21.03
Dividend yield:
0%
P/E ratio:
19.49x
P/S ratio:
1.11x
P/B ratio:
1.20x
Volume:
932.6K
Avg. volume:
620K
1-year change:
39.84%
Market cap:
$2.2B
Revenue:
$2.6B
EPS (TTM):
$0.96
Analysts' Opinion
-
Consensus RatingSiriusPoint has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $23.00, SiriusPoint has an estimated upside of 22.93% from its current price of $18.71.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 100% downside risk from its current price of $18.71.
Fair Value
-
According to the consensus of 2 analysts, SiriusPoint has 22.93% upside to fair value with a price target of $23.00 per share.
SPNT vs. S&P 500
-
Over the past 5 trading days, SiriusPoint has underperformed the S&P 500 by -1.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SiriusPoint does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SiriusPoint has grown year-over-year revenues for 1 quarter straight. In the most recent quarter SiriusPoint reported revenues of $729.4M.
Earnings Growth
-
SiriusPoint has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SiriusPoint reported earnings per share of $0.49.
Enterprise value:
-304.3M
EV / Invested capital:
--
Price / LTM sales:
1.11x
EV / EBIT:
-1.13x
EV / Revenue:
-0.11x
PEG ratio (5yr expected):
0.27x
EV / Free cash flow:
4.17x
Price / Operating cash flow:
41.81x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.32%
Net Income Margin (TTM):
6.28%
Return On Equity:
6.95%
Return On Invested Capital:
5.42%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.5B | $2.7B | $2.7B | $688.9M | $729.4M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$0.42 | $1.62 | $0.96 | $0.49 | $0.49 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.6B | $5.5B | $9.2B | $8.8B | $8.7B | |
| Total Assets | $10.2B | $10.9B | $11.8B | $13.1B | $12.3B | |
| Current Liabilities | $709.4M | $994.3M | $1.3B | $1.8B | $1.7B | |
| Total Liabilities | $7.6B | $8.6B | $9.6B | $10.5B | $10.3B | |
| Total Equity | $2.6B | $2.3B | $2.2B | $2.6B | $2B | |
| Total Debt | $829M | $808.4M | $779.2M | $770.6M | $663.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $387.4M | $545.9M | -$73M | $58.8M | -$88.9M | |
| Cash From Investing | -$1.2B | -$419.1M | $1B | -$80.8M | $610.9M | |
| Cash From Financing | -$41.9M | -$15M | -$1.1B | $7.1M | -$491.4M | |
| Free Cash Flow | $387.4M | $545.9M | -$73M | $58.8M | -$88.9M | |
SPNT
Sector
Market Cap
$2.2B
$627.9M
Price % of 52-Week High
88.97%
89.42%
Dividend Yield
0%
1.97%
Shareholder Yield
--
4.06%
1-Year Price Total Return
39.84%
7.77%
Beta (5-Year)
0.861
0.585
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
9.6%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$18.81
200-day SMA
Buy
Level
$16.06
Bollinger Bands (100)
Buy
Level
15.68 - 19.56
Chaikin Money Flow
Sell
Level
-15.1K
20-day SMA
Sell
Level
$19.39
Relative Strength Index (RSI14)
Sell
Level
43.94
ADX Line
Sell
Level
25.53
Williams %R
Neutral
Level
-79.2323
50-day SMA
Sell
Level
$19.38
MACD (12, 26)
Buy
Level
5.08
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Sell
Level
-1.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1407)
Sell
CA Score
(Annual)
Level (-1.7684)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.2874)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
Stock Forecast FAQ
In the current month, SPNT has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SPNT average analyst price target in the past 3 months is $23.00.
-
Where Will SiriusPoint Stock Be In 1 Year?
According to analysts, the consensus estimate is that SiriusPoint share price will rise to $23.00 per share over the next 12 months.
-
What Do Analysts Say About SiriusPoint?
Analysts are divided on their view about SiriusPoint share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SiriusPoint is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is SiriusPoint's Price Target?
The price target for SiriusPoint over the next 1-year time period is forecast to be $23.00 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SPNT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SiriusPoint is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of SPNT?
You can purchase shares of SiriusPoint via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SiriusPoint shares.
-
What Is The SiriusPoint Share Price Today?
SiriusPoint was last trading at $19.10 per share. This represents the most recent stock quote for SiriusPoint. Yesterday, SiriusPoint closed at $18.71 per share.
-
How To Buy SiriusPoint Stock Online?
In order to purchase SiriusPoint stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
